Department of Genetics, University of Groningen, University Medical Center Groningen, Hanzeplein 1, P.O. Box 30.001, Groningen, 9700 RB, The Netherlands.
Fam Cancer. 2024 Jun;23(2):155-164. doi: 10.1007/s10689-023-00356-x. Epub 2024 Jan 6.
Inherited cardiovascular diseases cover the inherited cardiovascular disease familial hypercholesterolemia and inherited cardiac diseases, like inherited cardiomyopathies and inherited arrhythmia syndromes. Cascade genetic counseling and testing in inherited cardiovascular diseases have had three decades of academic attention. Inherited cardiovascular diseases affect around 1-2% of the population worldwide and cascade genetic counseling and testing are considered valuable since preventive measures and/or treatments are available. Cascade genetic counseling via a family-mediated approach leads to an uptake of genetic counseling and testing among at-risk relatives of around 40% one year after identification of the causal variant in the proband, with uptake remaining far from complete on the long-term. These findings align with uptake rates among relatives at-risk for other late onset medically actionable hereditary diseases, like hereditary cancer syndromes. Previous interventions to increase uptake have focused on optimizing the process of informing relatives through the proband and on contacting relatives directly. However, despite successful information dissemination to at-risk relatives, these approaches had little or no effect on uptake. The limited research into the barriers that impede at-risk relatives from seeking counseling has revealed knowledge, attitudinal, social and practical barriers but it remains unknown how these factors contribute to the decision-making process for seeking counseling in at-risk relatives. A significant effect on uptake of genetic testing has only been reached in the setting of familial hypercholesterolemia, where active information provision was accompanied by a reduction of health-system-related barriers. We propose that more research is needed on barriers -including health-system-related barriers- and how they hinder counseling and testing in at-risk relatives, so that uptake can be optimized by (adjusted) interventions.
遗传性心血管疾病包括家族性高胆固醇血症等遗传性心血管疾病和遗传性心脏病,如遗传性心肌病和遗传性心律失常综合征。遗传性心血管疾病的级联遗传咨询和检测已经引起了学术界三十年的关注。遗传性心血管疾病影响全球约 1-2%的人口,由于有预防措施和/或治疗方法,级联遗传咨询和检测被认为是有价值的。通过家族介导的方法进行级联遗传咨询,可使约 40%的高危亲属在发现先证者的致病变异后一年内接受遗传咨询和检测,而长期来看,接受率仍远未达到完全接受。这些发现与其他迟发性可治疗遗传性疾病(如遗传性癌症综合征)高危亲属的接受率一致。以前增加接受率的干预措施侧重于通过先证者优化告知亲属的过程,并直接联系亲属。然而,尽管成功地将信息传递给高危亲属,但这些方法对接受率几乎没有影响。对阻碍高危亲属寻求咨询的障碍的有限研究揭示了知识、态度、社会和实际障碍,但仍不清楚这些因素如何影响高危亲属寻求咨询的决策过程。只有在家族性高胆固醇血症的情况下,遗传检测的接受率才会显著提高,因为在这种情况下,积极的信息提供伴随着减少了与卫生系统相关的障碍。我们建议,需要更多的研究来了解障碍,包括与卫生系统相关的障碍,以及它们如何阻碍高危亲属的咨询和检测,以便通过(调整后的)干预措施来优化接受率。